Family Planning for a Prosperous Future
Investing in policies, partnerships, and innovations to strengthen reproductive health care, end unmet needs, and support sustainable development
A Special Report from FP Analytics, with support from Bayer

MARCH 2025
Introduction
Sexual and reproductive health and rights (SRHR) represent a critical building block in global health and sustainable development by creating the basis for healthier, longer lives, enabling educational and professional attainment, and underpinning gender equality. The manifold returns of investment in SRHR—in the areas of health, socioeconomic development, peace and security, and the environment—present a range of inter-generational benefits on the order of trillions of dollars over time. The importance of SRHR, and particularly family planning and reproductive health services, is enshrined in global commitments including the International Conference on Population and Development (ICPD) Programme of Action, the Beijing Declaration and Platform of Action, and the United Nations Sustainable Development Goals (UN SDGs). Nevertheless, in recent years, many countries and regions have experienced stalling and backsliding on progress in furthering family planning and reproductive health.
Against the backdrop of complex crises such as armed conflicts, climate-driven natural disasters, supply chain disruptions, and rapidly evolving health emergencies, family planning and reproductive health services have been de-prioritized in recent years. During the COVID-19 pandemic, many countries experienced lockdowns and health care system strain, which deterred sexual and reproductive health-seeking behaviors and redirected funding. Meanwhile, the number of women and girls living in conflict-affected countries increased by 50 percent between 2013 and 2023, disrupting primary health services and leading to an uptick in sexual and gender-based violence. In addition to the impacts of what has been described as a global polycrisis, the politicization of family planning and reproductive health services in various parts of the world is further complicating and curtailing bilateral and multilateral financing and policymaking for SRHR, and contributing to shrinking space for civil society actors.
The landscape of funding for reproductive health is a complex one where a range of stakeholders, from governments to bilateral and multilateral donor agencies, philanthropic foundations, and others play an important role mobilizing resources and shaping programmatic priorities. In 2023, donor government funding for family planning was USD 1.47 billion but still fell short of the pre-pandemic level of USD 1.58 billion in 2019. Even when funding is pledged, it may not be disbursed for its intended use, or at all. At the current rate at which investments are made, and without increased and transparent financing—both domestic and international—the commodity financing gap for family planning in the world’s poorest countries could amount to USD 1.5 billion by 2030. Funding shortfalls and bottlenecks, combined with inadequate last-mile delivery of commodities and care due to ill-equipped infrastructure or governance systems, risk stagnating progress on family planning and reproductive health.
At the current rate at which investments are made, and without increased and transparent financing—both domestic and international—the commodity financing gap for family planning in the world’s poorest countries could amount to USD 1.5 billion by 2030.
Reflecting the combined effects of these compounding challenges, recent family planning and reproductive health data indicate a slowdown in momentum to meet global targets. As of 2024, the UN Population Division estimated that 258.5 million women around the world face unmet need for modern family planning methods, 87 percent of whom live in low- and middle-income countries (LMICs). The COVID-19 pandemic disrupted contraceptive use for tens of millions of women and resulted in an estimated 1.4 million unintended pregnancies in 2020 across 115 countries. Meanwhile, although maternal deaths decreased by 34 percent between 2000 and 2020—a significant public health victory—progress has stagnated in recent years, with the average rate of reduction between 2016 and 2020 falling short of targets. At 223 deaths per 100,000 live births, the current global maternal mortality ratio is three times higher than the SDG goal of reducing maternal mortality to 70 per 100,000 live births by 2030. In addition, as of 2023, 39.9 million people globally were living with HIV, with women and girls accounting for 44 percent of all new HIV cases. All of these indicators contribute to the delay in closing the gender gap—which no country is on track to achieve by 2030—and in meeting critical sexual and reproductive health goals.
FIGURE 1
Key Indicators of Family Planning and Unmet Need
Regions with high unmet need for family planning also face high maternal mortality, high adolescent birth rates, and gender inequality.
Maternal mortality dropped by 34 percent globally between 2000 and 2020, but the average of 223 deaths per 100,000 live births remains far above the SDG target of 70.
Global progress in reducing adolesecent pregnancies remains uneven, with Sub-Saharan Africa recording the highest rate at 97.9 births per 1,000 women aged 15-19 years.
Gender equality stagnated or declined in nearly 40 percent of countries from 2019 to 2022, affecting more than 1.1 billion women and girls.
Sources: UN Population Division (2024 data), Equal Measures 2030 (2022 data), WHO (2020), and WHO (data latest year available)
The year 2025 represents a critical juncture for reflection, redoubling of efforts, and reinforcement of the pathway to progress in family planning and reproductive health, marking six years since the Guttmacher-Lancet Commission report, 30 years since the ICPD and the Beijing Declaration, and just five years until the SDG deadline. As such, 2025 provides an opportunity for key stakeholders—from multilateral institutions, to governments, to non-governmental organizations (NGOs)—to reaffirm their commitments to eliminating unmet need for SRHR and achieving reproductive health and family planning goals.
To that end, this special report, produced by FP Analytics with support from Bayer, identifies areas of unmet need and barriers to progress toward family planning and reproductive health goals, analyzes the benefits of intervention, and provides insights into the state of SRHR programs and financing in the post-COVID-19 era. Consisting of a global landscape analysis and in-depth case studies on five LMICs with significant unmet need—Brazil, Ethiopia, India, Indonesia, and Nigeria—this report highlights scalable recommendations to close gaps in research, policy, investment, and partnership, seeking to catalyze concerted action.